MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0. It has been cited 31 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S National Institutes of Health (NIH)
Grant: R01CA237027
U.S National Institutes of Health (NIH)
Grant: R01CA240290
U.S National Institutes of Health (NIH)
Grant: R21CA237939
U.S National Institutes of Health (NIH)
Grant: R21CA218635
U.S National Institutes of Health (NIH)
Grant: P30CA016056
National Institutes of Health
Grant: 5R01CA237027-03
Tumor-Suppressive Functions and Molecular Regulation of LRIG1 in Prostate Cancer and CRPC
National Institutes of Health
Grant: 1R01CA240290-01
Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells
National Institutes of Health
Grant: 1R21CA218635-01A1
Slow-cycling cells, therapy resistance and clinical implications in prostate cancer
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
National Institutes of Health
Grant: 1R21CA237939-01A1
Correlative efficacy, biomarker, and mechanistic studies associated with a phase Ib/II clinical trial of treating mCRPC patients with enzalutamide and Venetoclax
FWCI
2.27
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals